Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Other Non-Current Assets (2020 - 2023)

Candel Therapeutics' Other Non-Current Assets history spans 4 years, with the latest figure at $300000.0 for Q3 2023.

  • For Q3 2023, Other Non-Current Assets rose 12.78% year-over-year to $300000.0; the TTM value through Sep 2023 reached $300000.0, up 12.78%, while the annual FY2022 figure was $300000.0, 29.25% down from the prior year.
  • Other Non-Current Assets for Q3 2023 was $300000.0 at Candel Therapeutics, up from $266000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.7 million in Q2 2021 and bottomed at $266000.0 in Q2 2022.
  • The 4-year median for Other Non-Current Assets is $300000.0 (2022), against an average of $458454.5.
  • The largest annual shift saw Other Non-Current Assets grew 21.49% in 2021 before it tumbled 84.46% in 2022.
  • A 4-year view of Other Non-Current Assets shows it stood at $349000.0 in 2020, then rose by 21.49% to $424000.0 in 2021, then decreased by 29.25% to $300000.0 in 2022, then changed by 0.0% to $300000.0 in 2023.
  • Per Business Quant, the three most recent readings for CADL's Other Non-Current Assets are $300000.0 (Q3 2023), $266000.0 (Q2 2023), and $300000.0 (Q1 2023).